AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 782976
Drug: Vaccine B
RxNorm normalized name: meningococcal vaccine B and C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine B (without galactose)
Trial: 26848182
Drug: Iron sulfate
RxNorm normalized name: iron sulfate (1:1)
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iron sulfate (oral)
Trial: 26848182
Drug: Iron sucrose
RxNorm normalized name: Iron Sucrose
DrugBank: Iron sucrose (DB09146)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron sucrose (intravenous)
Trial: 25096309
Drug: 1500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg/day oral glucosamine sulphate
Trial: 10463374
Drug: Imipramine (235
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (235 mg/day)
Trial: 10463374
Drug: Mirtazapine (77
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (77 mg/day)
Trial: 31274485
Drug: Furosemide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (1 mg/kg at induction of anesthesia)
Trial: 21486552
Drug: Sankang Capsule
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sankang Capsule
Trial: 21486552
Drug: Rhodiola Rosea
RxNorm normalized name: RHODIOLA ROSEA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhodiola Rosea Capsule
Trial: 21486552
Drug: Shenqi Pollen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenqi Pollen Capsule
Trial: 19271173
Drug: Yixuesheng capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yixuesheng capsule (YXS) combined with recombination human erythropoietin (RHE)
Trial: 16982228
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (EE 20 microg/day and norelgestromin 150 microg/day)
Trial: 16982228
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (EE 35 microg and norgestimate 250 microg)
Trial: 15208650
Drug: Amifostine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (1000 mg/day during conditioning)
Trial: 1696671
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Digoxin and Quinapril
Trial: 27889307
Drug: Tranexamic Acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic Acid (TA) 15 mg/kg (Group B)
Trial: 27889307
Drug: Tranexamic Acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic Acid (TA) 10 mg/kg (Group C)
Trial: 27889307
Drug: Tranexamic Acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic Acid (TA) 30 mg/kg (Group A)
Trial: 25894177
Drug: Dextrose in
RxNorm normalized name: dextrose in water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose in water plus insulin infusion (group 1)
Trial: 25894177
Drug: Dextrose in
RxNorm normalized name: dextrose in water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose in water infusion (group 2)
Trial: 17588810
Drug: Atomoxetine (ATX)
DrugBank: Atomoxetine (DB00289)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atomoxetine (ATX) treatment for one month
Trial: 7843574
Drug: Psychiatric consultation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychiatric consultation letter providing treatment recommendations
Trial: 30740133
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maintained daily routine activities without regular exercise)
Trial: 24990423
Drug: 1.5 kcal/mL
RxNorm normalized name: lactose-reduced food 0.05 gram-1.5 kcal/mL ORAL LIQUID (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 kcal/mL enteral nutrition solution
Trial: 24990423
Drug: 1.0 kcal/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 kcal/mL enteral nutrition solution
Trial: 22798383
Drug: Group 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1: 1.10 mL/kg for men and women
Trial: 22798383
Drug: Group 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2: men 1.10 mL/kg, women 0.99 mL/kg
Trial: 15734772
Drug: Adhesive patch
RxNorm normalized name: ADHESIVE PATCH, MEDICATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adhesive patch electrodes
Trial: 15734772
Drug: Patch electrodes
RxNorm normalized name: ELECTRODE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch electrodes after cross-over
Trial: 12390611
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g intravenous dipyrone
Trial: 12390611
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL 0.9% physiological saline (placebo)
Trial: 2214124
Drug: Oral ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ranitidine (0.4 mg.kg‐1)
Trial: 2214124
Drug: Intramuscular ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular ranitidine (0.1 mg.kg‐1)
Trial: 26547662
Drug: Current use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current use of metformin
Trial: 26547662
Drug: Past use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Past use of metformin
Trial: 24160184
Drug: Teacher professional
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teacher professional development (6 days) aimed at improving expressive and receptive oral language skills and early literacy; included school-based continuing contact and completion of a postgraduate unit on early language and literacy.
Trial: 22677258
Drug: CAD106 50
RxNorm normalized name: CAD106
DrugBank: CAD106 (DB05150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAD106 50 μg
Trial: 22677258
Drug: CAD106 150
RxNorm normalized name: CAD106
DrugBank: CAD106 (DB05150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAD106 150 μg
Trial: 21125811
Drug: Chlortalidone (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlortalidone (12.5 mg/day)
Trial: 21125811
Drug: Trichlormethiazide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trichlormethiazide (1 mg/day)
Trial: 15802115
Drug: Customary treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Customary treatments (control group)
Trial: 8840945
Drug: Nystatin tablets
RxNorm normalized name: Nystatin Tablets
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nystatin tablets 500,000 units four times a day
Trial: 6434423
Drug: Essential amino
RxNorm normalized name: Essential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential amino acids infusion (group 1)
Trial: 6434423
Drug: Combined essential
RxNorm normalized name: OILS,ESSENTIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined essential and non-essential amino acids infusion (group 2)
Trial: 6434423
Drug: Routine laboratory
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine laboratory data and protein metabolism parameters (both groups)
Trial: 27750364
Drug: Pneumatic unloader
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumatic unloader brace and conventional treatment
Trial: 24417765
Drug: Drug used
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug used for cardioversion (Propafenone vs Vernakalant)
Trial: 19997723
Drug: High diuresis
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High diuresis (Group D) - pressure infusion of approximately 1 L of Ringer acetate solution and 20 mg of furosemide during a 30-40 min treatment session.
Trial: 19012818
Drug: 30 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/day lisdexamfetamine
Trial: 19012818
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day lisdexamfetamine
Trial: 19012818
Drug: 70 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg/day lisdexamfetamine
Trial: 15867832
Drug: Asthma education
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma education program (Open Airways) followed by 5 monthly visits with a nurse practitioner
Trial: 31547503
Drug: Anthocyanin-rich antioxidant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthocyanin-rich antioxidant juice (AJ), dosage: 240 mL twice-a-day for nine days
Trial: 31547503
Drug: Placebo (PLA),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLA), dosage: 240 mL twice-a-day for nine days
Trial: 21268098
Drug: Rectal distension
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal distension (150 ml of normal saline)
Trial: 22275153
Drug: Rectal distension
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal distension
Trial: 9782139
Drug: Preoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative administration of two injections of a depot formulation of leuprolide acetate 28 days apart
Trial: 31295916
Drug: Maternal lipid‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal lipid‐based nutrient supplement (LNS)
Trial: 27408987
Drug: Mushroom blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mushroom blend containing Cordyceps militaris (4 g·d‐1)
Trial: 26009024
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of cotrimoxazole (CTX) prophylaxis
Trial: 21298654
Drug: Atorvastatin 5
RxNorm normalized name: amlodipine-atorvastatin 5 mg-80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 5 mg/ezetimibe 5 mg
Trial: 19026531
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia (thiopental 4 mg/kg, succinylcholine 1-1.5 mg/kg, 1% end-tidal concentration of sevoflurane in nitrous oxide and 50% oxygen)
Trial: 19026531
Drug: Neuraxial anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuraxial anesthesia (intrathecal 0.5% levobupivacaine 1.8-2.2 mL and epidural fentanyl 1 microg/kg)
Trial: 16883221
Drug: Gemfibrozil (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (600 mg b.i.d for 90 days)
Trial: 15536776
Drug: Disulfiram (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disulfiram (1500 mg weekly in divided doses)
Trial: 11421840
Drug: 75 mg/ml
RxNorm normalized name: urea 375 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg/ml (7.5%) hypertonic saline (HS) administered at 1.6 ml/kg
Trial: 11421840
Drug: 9 mg/ml
RxNorm normalized name: iodine 9 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 mg/ml normal saline administered at 13 ml/kg
Trial: 11421840
Drug: 75 mg/ml
RxNorm normalized name: urea 375 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg/ml (7.5%) hypertonic saline (HS)
Trial: 11421840
Drug: 9 mg/ml
RxNorm normalized name: iodine 9 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 mg/ml normal saline
Trial: 25629793
Drug: Intranasal budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal budesonide and isotonic nasal saline for 2 weeks
Trial: 16977442
Drug: 80 ml
RxNorm normalized name: urinary bag 480 mL MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 ml contrast material at 2.0 ml/s
Trial: 16977442
Drug: 80 ml
RxNorm normalized name: urinary bag 480 mL MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 ml contrast material followed by 40 ml saline at 2.0 ml/s
Trial: 16977442
Drug: 60 ml
RxNorm normalized name: Disposable Nurser 60 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 ml contrast material at 1.5 ml/s
Trial: 16977442
Drug: 60 ml
RxNorm normalized name: Disposable Nurser 60 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 ml contrast material followed by 30 ml saline at 1.5 ml/s
Trial: 16977442
Drug: Saline chaser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline chaser (40 ml or 30 ml)
Trial: 15074087
Drug: Xuesaitong injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuesaitong injection (XSTI)
Trial: 11190987
Drug: Choline chloride
RxNorm normalized name: Choline Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline chloride (2 g) added to usual TPN regimen
Trial: 9613534
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 0.9% saline injected into the epidural catheter
Trial: 9613534
Drug: 1 mL
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mL 0.9% saline injected into the epidural catheter
Trial: 8578840
Drug: Hib vaccine
RxNorm normalized name: ActHIB vaccine 0.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hib vaccine mixed with whole‐cell DTP vaccine
Trial: 8578840
Drug: Hib vaccine
RxNorm normalized name: ActHIB vaccine 0.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hib vaccine administered in separate limbs from whole‐cell DTP vaccine
Trial: 2517007
Drug: Rilmenidine (RIL)
DrugBank: Rilmenidine (DB11738)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine (RIL) 1 mg every morning or 1 mg twice daily if necessary
Trial: 2517007
Drug: Methyldopa (MD)
RxNorm normalized name: Methyldopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methyldopa (MD) 250 mg morning and evening or 500 mg twice daily if necessary
Trial: 27684085
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL LMWF-5A
Trial: 18058852
Drug: Escitalopram (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (mean dose 26.5 mg/day)
Trial: 12626460
Drug: RNase L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RNase L 37-kDa/83-kDa ratio
Trial: 11088083
Drug: Topical zanamivir
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Topical zanamivir (combined inhaled and intranasal zanamivir, inhaled zanamivir)
Trial: 11088083
Drug: Intranasal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal and inhaled zanamivir
Trial: 9052309
Drug: Inhaled anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled anesthesia (Group II)
Trial: 1586184
Drug: Caffeine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (12.5 mg/kg loading dose and 3 mg/kg daily maintenance)
Trial: 1586184
Drug: Caffeine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (25 mg/kg loading and 6 mg/kg daily maintenance)
Trial: 1586184
Drug: Theophylline (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (7.5 mg/kg loading and 3 mg/kg thrice daily maintenance)
Trial: 24457404
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg tid for 6 months
Trial: 21168874
Drug: Testosterone 150
RxNorm normalized name: testosterone 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone 150 mg + Dutasteride 0.25 mg
Trial: 21168874
Drug: Testosterone 250
RxNorm normalized name: testosterone 250 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone 250 mg + Dutasteride 0.25 mg
Trial: 21168874
Drug: Testosterone 400
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone 400 mg + Dutasteride 0.25 mg
Trial: 21168874
Drug: Testosterone 400
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone 400 mg
Trial: 21168874
Drug: Dutasteride 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.25 mg
Trial: 8694310
Drug: droperidol 0.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: droperidol 0.65 mg i.v.
Trial: 8694310
Drug: droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: droperidol 1.25 mg i.v.
Trial: 8694310
Drug: droperidol 0.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: droperidol 0.65 mg i.v. and 1.25 mg i.v.
Trial: 30453660
Drug: Dietary fiber
RxNorm normalized name: Dietary Fiber 1.67 GM Oral Tablet, Chewable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary fiber intake increased from 19 g/day to 29 g/day
Trial: 27002500
Drug: HIVAX vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIVAX vaccine (replication-defective HIV-1 vaccine)
Trial: 27002500
Drug: HIVAX vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIVAX vaccine
Trial: 16641918
Drug: Chelation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chelation therapy with calcium disodium ethylenediaminetetraacetic acid (EDTA) weekly until body lead burden fell <60 microg for 3 months.
Trial: 16641918
Drug: Placebo (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (control group) received weekly placebo for 3 months.
Trial: 7752916
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN) with L-amino acid mixture, supplying 0.36 g N.kg‐1.d‐1
Trial: 2300922
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of methylprednisolone (HDC)
Trial: 22289557
Drug: 2 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 μg/kg fentanyl bolus
Trial: 22289557
Drug: Priming dose
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Priming dose of fentanyl 0.5 μg/kg followed by 1.5 μg/kg after 1 min
Trial: 22289557
Drug: Priming dose
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Priming dose of fentanyl 0.5 μg/kg followed by 1.5 μg/kg after 2 min
Trial: 22289557
Drug: Priming dose
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Priming dose of fentanyl 0.5 μg/kg followed by 1.5 μg/kg after 3 min
Trial: 22289557
Drug: Fentanyl priming
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl priming dose
Trial: 16757523
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid treatment
Trial: 15282657
Drug: Anti-PF4/heparin antibodies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-PF4/heparin antibodies
Trial: 11159092
Drug: Power injection
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Power injection through central venous catheter
Trial: 9285658
Drug: Ibutilide (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide (0.01 then 0.002 mg/kg)
Trial: 9285658
Drug: Ibutilide (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide (0.02 then 0.004 mg/kg)
Trial: 9285658
Drug: Ibutilide (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide (0.03 then 0.006 mg/kg)
Trial: 3828181
Drug: Regular timed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular timed injections of bupivacaine (0.5%, 0.375%, 0.25%)
Trial: 3828181
Drug: On demand
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On demand injections of bupivacaine (0.5%, 0.375%, 0.25%)
Trial: 3828181
Drug: Regular top-up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular top-up injections
Trial: 31355467
Drug: Pevonedistat in
RxNorm normalized name: Pevonedistat
DrugBank: Pevonedistat (DB11759)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pevonedistat in combination with azacitidine
Trial: 29508904
Drug: Low vitamin
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low vitamin B12 status (<234 pmol/L; 317 pg/mL)
Trial: 29508904
Drug: Elevated homocysteine
RxNorm normalized name: mecysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated homocysteine (>15 µmol/L)
Trial: 23948685
Drug: Intensive activity-based
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive activity-based therapy applied during the critical period (younger than 2 years)
Trial: 23948685
Drug: Previous activity-based
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Previous activity-based therapies
Trial: 16622438
Drug: Adjuvant oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant oral capecitabine
Trial: 16622438
Drug: Adjuvant intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant intravenous 5-FU/LV
Trial: 12630027
Drug: Interferon and
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon and amantadine hydrochloride (100 mg orally daily) for 26 weeks